MYRIAD GENETICS, INC. Payments for Software
MYRIAD GENETICS, INC. (MYGN) reported Payments for Software of $10.70 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForSoftware · last filed 2025-02-28
- MYRIAD GENETICS, INC. payments for software for the quarter ending 2024-12-31 was $2.30M, a 34.29% decline year-over-year.
- MYRIAD GENETICS, INC. payments for software for the quarter ending 2024-09-30 was $2.80M, a 57.58% decline year-over-year.
- MYRIAD GENETICS, INC. payments for software for the quarter ending 2024-06-30 was $3.70M.
- MYRIAD GENETICS, INC. payments for software for the quarter ending 2024-03-31 was $1.90M.
- MYRIAD GENETICS, INC. payments for software for fiscal 2024 was $10.70M, a 5.94% increase from fiscal 2023.
- MYRIAD GENETICS, INC. payments for software for fiscal 2023 was $10.10M.
- MYRIAD GENETICS, INC. payments for software for fiscal 2022 was $0.00.
- MYRIAD GENETICS, INC. payments for software for fiscal 2021 was $0.00.
| Period end | Payments for Software 3 month | Payments for Software 6 month | Payments for Software 9 month | Payments for Software 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $5.10M derived: sum of 2 quarters · filed 2025-02-28 | $8.80M derived: sum of 3 quarters · filed 2025-02-28 | $10.70M 10-K · filed 2025-02-28 |
| 2024-09-30 | $2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $6.50M derived: sum of 2 quarters · filed 2024-11-08 | $8.40M 10-Q · filed 2024-11-08 | $11.90M derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-06-30 | $3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $5.60M 10-Q · filed 2024-08-07 | $9.10M derived: sum of 3 quarters · filed 2025-02-28 | $15.70M derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-03-31 | $1.90M 10-Q · filed 2024-05-08 | $5.40M derived: sum of 2 quarters · filed 2025-02-28 | $12.00M derived: sum of 3 quarters · filed 2025-02-28 | $12.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $10.10M derived: sum of 2 quarters · filed 2025-02-28 | $10.10M derived: sum of 3 quarters · filed 2025-02-28 | $10.10M 10-K · filed 2025-02-28 |
| 2023-09-30 | $6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $6.60M derived: sum of 2 quarters · filed 2024-11-08 | $6.60M 10-Q · filed 2024-11-08 | $6.60M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |